22nw, LP
22NW, LP is a Seattle-based hedge fund and investment adviser founded in 2015, with approximately 6 employees. The firm manages pooled investment vehicles primarily for US institutional and accredited investors and reports regulatory filings with the SEC. 22NW’s investment team focuses on fundamental-driven, concentrated equity strategies.
Investment Strategy
22NW, LP employs a concentrated, fundamental value-focused equity strategy. It seeks investment opportunities across industries, concentrating capital in its best ideas based on extensive research and analysis. The firm often takes activist positions in small- and mid-cap companies, aiming to unlock shareholder value through operational improvements, strategic changes, and board engagement. 22NW manages discretionary portfolios and follows a long-term investment philosophy, targeting compelling risk/reward profiles.
Top Holdings
Equity Positions (19)
| Ticker | Security | Weight | Market Value | Shares | Avg Cost | Price | Change (QoQ) |
|---|---|---|---|---|---|---|---|
F FSTR | FOSTER L B CO | 18.08% | $28.7M | 1,313,121 | $15.00 | $21.87 | +$2.9M |
L LFCR | LIFECORE BIOMEDICAL INC | 14.25% | $22.6M | 264,180 | $10.23 | $8.12 | -$7.2M |
A ANEB | ANEBULO PHARMACEUTICALS INC | 14.03% | $22.3M | 15,467,300 | $2.93 | $1.44 | +$2.2M |
S SRI | STONERIDGE INC | 8.62% | $13.7M | 1,943,508 | $5.28 | $7.04 | +$6.2M |
D DHX | DHI GROUP INC | 6.17% | $9.8M | 3,299,937 | $2.36 | $2.97 | +$6.2M |